Home/Filings/4/0001179110-19-005165
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-19-005165

CIK 0001292519other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 9:43 PM ET

Size

10.1 KB

Accession

0001179110-19-005165

Insider Transaction Report

Form 4
Period: 2019-04-22
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-04-22$1.45/sh79$11510,693 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,228
Footnotes (2)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 250 stock-settled RSUs.
  • [F2]The reporting person holds 5,228 shares of NVIV common stock under the NVIV 401(k) plan. The information in this report is based on a plan statement dated as of April 24, 2019.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 9:43 PM ET
Size
10.1 KB